The POTS, CFS/ME, CRPS diagnostic is performed every 14 days in our lab. The next date is the 7th April 2020. If you want to send us your sample, please fill out the form completely (important: email address and signature) and send it to our lab in Germany. For guide of blood preparation, please click…Details
CellTrend passed the monitoring audit for ISO 13485! Our management system fulfills the required standards for development and production of immunologic assays, cell culture systems and in-vitro-diagnostics again!
Human papillomavirus (HPV) infection promotes uterine and cervical cancers. In 2010, HPV vaccines were introduced worldwide. Since then case series of suspected adverse effects after HPV vaccination have been reported from several countries and the symptoms described by independent researchers are similar. In this study, autoantibodies against diverse Gprotein coupled receptors in the serum of…Details
The first Meeting on Chronic Fatigue in Immune-mediated disorders takes place in November 21/22 2019 in Berlin! Renowned scientists speak about the topics clinical presentation, diagnostic tools, pathomechanism and the treatment of Fatigue. Read more about it here!Details
New study in Journal of American Heart Association about POTS published: Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G‐Protein Coupled Receptor Autoantibodies. William T. GunningIII , Heather Kvale , Paula M. Kramer , Beverly L. Karabin , and Blair P. Grubb The aim of this study was to detect both the presence and prevalence…Details
Meet us at the 14th Dresden Symposium on Autoantibodies taking place from September 10 to September 13, 2019! The main topic of the upcoming symposium deals with the role of autoantibodies in precision health and precision medicine. Further topics: ★ Autoantibodies in systemic and organ specific autoimmune diseases (induction, pathology, clinical relevance) ★ Novel autoantibodies…Details
Dr. Kai Schulze-Forster, co-founder of CellTrend GmbH, was awarded the title of professor by the Technical University in Wildau. In a ceremonial act Prof. Dr. Ulrike Tippe, president of the TH Wildau, presented the certificate on Wednesday, 26th June 2019. The entire CellTrend Team congratulates Prof. Dr. Kai Schulze-Forster!Details
On May 17, 2019, the 20th anniversary of CellTrend took place. Numerous cooperation partners, customers and friends found their way to Luckenwalde on this day to celebrate with us. The audience was offered very interesting speeches by renowned scientists. Therefore we would like to thank Prof. Dr. med. Yehuda Shoenfeld (Sheba Medical Center, Tel Aviv),…Details
Read the abstract of this interesting article: Anti-angiotensin II type 1 receptor (AT1R) antibodies have been associated with allograft rejection. We hypothesized that circulating AT1R antibodies might identify kidney transplant recipients at increased risk of allograft rejection and loss who are not identified by the HLA system. We prospectively enrolled 1845 kidney transplant recipients from…Details
New publication in Frontiers in Bioscience about: Anti-ß1-Adrenoreceptor auto-Antibodies in elderly heart failure patients.
Abstract of the article: An autoimmune reaction directed against the cardiac b1-adrenergic receptor (beta1-ADR) leading to the generation of autoantibodies (AA) against this G-coupled receptor has been described in patients with heart failure (HF). Agonist-like beta1-ADR-AA are associated with morbidity in HF patients and even predict mortality. Standardised and valid diagnostic tools to detect beta…Details